{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:10:30Z","timestamp":1792181430658,"version":"4.4.0"},"reference-count":63,"publisher":"The Korean Academy of Family Medicine - M2PI","issue":"2","license":[{"start":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:00:00Z","timestamp":1709078400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003646","name":"National Health Insurance Service","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003646","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kjfm.or.kr"],"crossmark-restriction":true},"short-container-title":["Korean J Fam Med"],"published-print":{"date-parts":[[2024,3,20]]},"abstract":"<jats:p>Although major countries, such as South Korea, have developed and disseminated national smoking cessation guidelines, these efforts have been limited to developing individual societies or specialized institution-based recommendations. Therefore, evidence-based clinical guidelines are essential for developing smoking cessation interventions and promoting effective smoking cessation treatments. This guideline targets frontline clinical practitioners involved in a smoking cessation treatment support program implemented in 2015 with the support of the National Health Insurance Service. The Guideline Development Group of 10 multidisciplinary smoking cessation experts employed the Grading of Recommendations Assessment, Development, and Evaluation (GRADE)-ADOLOPMENT approach to review recent domestic and international research and guidelines and to determine evidence levels using the GRADE methodology. The guideline panel formulated six strong recommendations and one conditional recommendation regarding pharmacotherapy choices among general and special populations (mental disorders and chronic obstructive lung disease [COPD]). Strong recommendations favor varenicline rather than a nicotine patch or bupropion, using varenicline even if they are not ready to quit, using extended pharmacotherapy (&gt;12 weeks) rather than standard treatment (8\u201312 weeks), or using pharmacotherapy for individuals with mental disorders or COPD. The conditional recommendation suggests combining varenicline with a nicotine patch instead of using varenicline alone. Aligned with the Korean Society of Medicine\u2019s clinical guideline development process, this is South Korea\u2019s first domestic smoking cessation treatment guideline that follows standardized guidelines. Primarily focusing on pharmacotherapy, it can serve as a foundation for comprehensive future smoking cessation clinical guidelines, encompassing broader treatment topics beyond medications.<\/jats:p>","DOI":"10.4082\/kjfm.23.0142","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T03:12:07Z","timestamp":1709089927000},"page":"69-81","update-policy":"https:\/\/doi.org\/10.4082\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evidence-Based Guideline for the Treatment of Smoking Cessation Provided by the National Health Insurance Service in Korea"],"prefix":"10.4082","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8652-4355","authenticated-orcid":true,"given":"Cheol Min","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8116-1110","authenticated-orcid":true,"given":"Yoo-Bin","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9573-8849","authenticated-orcid":true,"given":"Yu-Jin","family":"Paek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6148-2512","authenticated-orcid":true,"given":"Eon Sook","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2096-7679","authenticated-orcid":true,"given":"Hye Seon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3205-9408","authenticated-orcid":true,"given":"Soo Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4557-3542","authenticated-orcid":true,"given":"Sungwon","family":"Roh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4538-6045","authenticated-orcid":true,"given":"Dong Won","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4548-0653","authenticated-orcid":true,"given":"Yoo Suk","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2063-1542","authenticated-orcid":true,"given":"Sang-Ho","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The Guideline Development Group for Developing the Korean Clinical Practice Guideline for Tobacco Cessation","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2550","reference":[{"key":"ref1","first-page":"2337","volume-title":"Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019","year":"2021"},{"key":"ref2","volume-title":"","year":"2011"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/add.14204"},{"key":"ref4","volume-title":"","year":"2020"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.21215\/kjfp.2021.11.6.403"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2016.09.009"},{"key":"ref7","volume-title":""},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.090449"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-7-10"},{"key":"ref10","first-page":"l4898","volume-title":"RoB 2: a revised tool for assessing risk of bias in randomized trials","author":"Sterne","year":"2019"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202005-1982st"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2007.090647"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(16)30272-0"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2012.01.004"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.19284"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.11.0183"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-2600(14)70294-2"},{"key":"ref18","first-page":"1808","volume-title":"Varenicline versus nicotine patch with brief advice for smokers with substance use disorders with or without depression: effects on smoking, substance use and depressive symptoms","author":"Rohsenow","year":"2017"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1253\/circj.cj-09-0803"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-016-0626-2"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.12548"},{"key":"ref22","volume-title":"Mechanistic Evaluations of Pre-Cessation Therapies for Smoking Cessation (ConNicBrain): NCT01406223 [Internet]","year":"2017"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd013308"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2073"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.1.56"},{"key":"ref26","first-page":"47","volume-title":"Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial","author":"Gonzales","year":"2006"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2013.678"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntr130"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.15.1561"},{"key":"ref30","volume-title":"The effect of varenicline (Chantix) and bupropion (Zyban) on smoking lapse behavior [Internet]","year":"2018"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1012433"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-014-0172-8"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2014.08.086"},{"key":"ref34","first-page":"1485","volume-title":"Effects of combined varenicline with nicotine patch and of extended treatment duration on smoking cessation: a randomized clinical trial","author":"Baker","year":"2021"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1002\/pon.4978"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1513\/annalsats.202110-1140oc"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.4065\/82.2.186"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.285113"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-135-6-200109180-00011"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.1.64"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-152-3-201002020-00005"},{"key":"ref42","first-page":"504","volume-title":"Long-term nicotine replacement therapy: a randomized clinical trial","author":"Schnoll","year":"2015"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1111\/add.13153"},{"key":"ref44","volume-title":"Extended varenicline treatment for smoking among cancer patients [Internet]","year":"2012"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2753.2008.01045.x"},{"key":"ref46","first-page":"416","volume-title":"The cost-effectiveness of an extended course (12+12 weeks) of varenicline plus brief counselling compared with other reimbursed smoking cessation interventions in Belgium, from a public payer perspective","author":"Knight","year":"2012"},{"key":"ref47","first-page":"1217","volume-title":"Treating tobacco use and dependence: 2008 update U.S. Public Health Service Clinical Practice Guideline executive summary","author":"and","year":"2008"},{"key":"ref48","first-page":"1036","volume-title":"Time for a change: putting the Transtheoretical (Stages of Change) Model to rest","author":"West","year":"2005"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200210000-00008"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.280"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntr103"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntr220"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1097\/jcp.0000000000001015"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.202000032"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1002\/da.22982"},{"key":"ref56","first-page":"429","volume-title":"The effects of varenicline, bupropion, nicotine patch, and placebo on smoking cessation among smokers with major depression: a randomized clinical trial","author":"Cinciripini","year":"2022"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00007212"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2020.1858796"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1080\/15412555.2019.1703928"},{"key":"ref60","first-page":"1571","volume-title":"Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomized trial","author":"Tashkin","year":"2001"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-0865"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1378\/chest.130.2.334"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.19.2286"}],"container-title":["Korean Journal of Family Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/kjfm.or.kr\/upload\/pdf\/kjfm-23-0142.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/kjfm.or.kr\/journal\/view.php?doi=10.4082\/kjfm.23.0142","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/kjfm.or.kr\/upload\/pdf\/kjfm-23-0142.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,24]],"date-time":"2024-03-24T19:45:22Z","timestamp":1711309522000},"score":1,"resource":{"primary":{"URL":"http:\/\/kjfm.or.kr\/journal\/view.php?doi=10.4082\/kjfm.23.0142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,20]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"URL":"https:\/\/doi.org\/10.4082\/kjfm.23.0142","relation":{},"ISSN":["2092-6715"],"issn-type":[{"value":"2092-6715","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,20]]},"assertion":[{"value":"2023-08-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-28","order":2,"name":"published","label":"Published online","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-20","order":3,"name":"published","label":"Print publication","group":{"name":"publication_history","label":"Publication History"}}]}}